drugset

drugset / Trial / NCT06058442

The Pancreatic Enzymes After Gastrectomy Trial

NCT06058442 ↗

Phase 3 Recruiting 188 enrolled University of Leipzig

RandomizedParallel-groupDouble-blindTreatment

Summary

This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.

Timeline

Start: 2024-01-24
Primary completion: 2027-06
Completion: 2027-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	NORTASE®	Unknown	—	—

Indications